Skip to content

Study on the pathogenesis of acoustic neuroma

Study on the pathogenesis of acoustic neuroma

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042035
Enrollment
Unknown
Registered
2021-01-12
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acoustic neuroma

Interventions

acoustic neuroma:None

Sponsors

Ophthalmology and Otolaryngology Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Through clinical symptoms and signs, auxiliary examination, enhanced magnetic resonance imaging and audiology examination, the patients are clinically diagnosed as acoustic neuroma; 2. The subjects who have reached the operation standard and performed the operation in our hospital; 3. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with other space occupying lesions in cerebellopontine angle; 2. Patients with other diseases that will affect the results and health of patients.

Design outcomes

Primary

MeasureTime frame
RNA-Seq sequencing of acoustic neuroma;Whole exon sequencing of peripheral blood;

Countries

China

Contacts

Public ContactDongdong Ren

Ophthalmology and Otolaryngology Hospital Affiliated to Fudan University

dongdong_ren@163.com+86 13801913332

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026